{"id":"W4324305894","doi":"10.2337/dc22-2200","title":"Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial","year":2023,"lang":"en","type":"article","venue":"Diabetes Care","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; U.S. National Library of Medicine; National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; Juvenile Diabetes Research Foundation United States of America; Novo Nordisk; Immune Tolerance Network; National Institute of Child Health and Human Development; Abbott Laboratories; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Sanofi; National Institute of Allergy and Infectious Diseases; Pfizer; Bristol-Myers Squibb; Juvenile Diabetes Research Foundation International","keywords":"Abatacept; Medicine; Placebo; Internal medicine; Type 2 diabetes; Diabetes mellitus; Clinical endpoint; Hazard ratio; Immune system; Randomized controlled trial; Immunology; Endocrinology; Gastroenterology; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001294117,0.001122272,0.002714026,0.0003934313,0.0004380011,0.0007484793,0.0006968088,0.001728029,0.00653285],"category_scores_gemma":[0.001965943,0.0004671679,0.001376942,0.0003799691,0.0005928069,0.0006765602,0.0002052318,0.001414501,0.0006617706],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005895332,"about_ca_system_score_gemma":0.000918815,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008204034,"about_ca_topic_score_gemma":0.001746725,"domain_scores_codex":[0.9993671,0.0003202503,0.00004905262,0.0001270548,0.00005463382,0.00008194471],"domain_scores_gemma":[0.9993429,0.0002493861,0.000170777,0.00003730981,0.00004763909,0.0001518991],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9764146,0.002773686,0.0003442654,0.001541939,0.0007902861,0.00005384287,0.00002846833,0.0001302962,0.001394548,0.00006652651,0.0006060816,0.01585542],"study_design_scores_gemma":[0.9825121,0.01601008,0.000646078,0.00006197004,0.0002442066,0.00002807552,0.000006948576,0.0001393487,0.00009712904,0.00004562612,0.0002032367,0.000005199381],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9644168,0.0227806,0.001130612,0.001039607,0.001825371,0.005194272,0.0009313171,0.0002261173,0.002455406],"genre_scores_gemma":[0.9811329,0.00684127,0.001856422,0.001199714,0.0009153299,0.005682819,0.0004013344,0.00001529911,0.001954874],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00653285,"threshold_uncertainty_score":0.02185458,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008513009647779438,"score_gpt":0.2701298714988331,"score_spread":0.2616168618510536,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}